Abstract | BACKGROUND: METHODS: In a consecutive series of 23 patients, closure was achieved in 83% of patients after a mean fistula duration of 11.0 +/- 7.9 days and a mean of 13.2 +/- 7.0 days of drug treatment, and without mortality. RESULTS: A marked first-day effect (output drop > 50%) was noted in 60% of patients and had a good prognosis. Infection of the fistula markedly prolonged fistula closure time, but did not affect total outcome. CONCLUSION:
|
Authors | D Ysebaert, R Van Hee, G Hubens, W Vaneerdeweg, E Eyskens |
Journal | Scandinavian journal of gastroenterology. Supplement
(Scand J Gastroenterol Suppl)
Vol. 207
Pg. 42-4
( 1994)
ISSN: 0085-5928 [Print] England |
PMID | 7701267
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Combined Modality Therapy
- Cutaneous Fistula
(therapy)
- Humans
- Intestinal Fistula
(therapy)
- Middle Aged
- Pancreatic Fistula
(therapy)
- Parenteral Nutrition, Total
- Postoperative Complications
(therapy)
- Prognosis
- Somatostatin
(therapeutic use)
|